Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation modalities and risk of hypercalcemia in children
2016-001807-22Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vitamin d in Vitamin D deficiency (VDD) and Not applicable (2 arms), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Hypercalciuria incidence. Started Jul 2016; status: active.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)Not applicable
Beyond the preview
Go deeper on 2016-001807-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001807-22.